NR 503: Infectious Disease Paper

NR 503: Infectious Disease Paper

Infectious diseases are significant health issues because they inflict a massive burden on people and healthcare systems. For instance, their transmission patterns affect population health, increase the costs of care, and result in other adverse consequences, including high mortality rates, prolonged hospitalization, comorbidities, and compromised quality of care. Shigellosis is an ideal example of an infectious disease that poses a significant challenge in current healthcare systems. According to Mayo Clinic (2020), shigella is a bacterium responsible for an intestinal infection that manifests through diarrhea, fever, nausea, vomiting, and stomach cramps. The bacterium is highly infectious and primarily affects people grappling with poor social determinants of health. Bajer & The (2018) argue that Shigella-associated diarrhea is responsible for about 1.3 million deaths annually, including approximately 500,000 young children globally. This paper analyzes the epidemiological information about Shigellosis, including causes, symptoms, transmission patterns, complications, and treatment, the demographic breakdown of the at-risk population, determinants of health, epidemiological triad, and the role of nurse practitioners in managing the infectious disease.

Analysis of the Communicable Disease


Struggling to meet your deadline ?

Get assistance on

NR 503: Infectious Disease Paper

done on time by medical experts. Don’t wait – ORDER NOW!

Shigellosis is a bacterial disease emanating from highly contagious Shigella bacillus. According to the Centers for Disease Control and Prevention [CDC] (2022), various factors increase the individual propensity to the pathogen. These factors include getting into contact with infected surfaces and foods, consuming raw foods, swallowing recreational water, and engaging in unprotected sexual activities. Cleveland Clinic (2022) contends that uncooked vegetables, contaminated water, and sexual contact with infected persons are the major causes of shigellosis and its subsequent transmission. The knowledge of these risk factors can inform preventive interventions and improve self-management interventions.


The clinical manifestation of shigellosis involves various symptoms that stem from the primary sign; diarrhea. The Centers for Disease Control and Prevention [CDC] (2021) argues that infected people demonstrate shigellosis symptoms within two days after contact with the pathogen. These symptoms include bloody, watery diarrhea, stomach crumbs and pain, fever, and vomiting. Equally, the disease may result in colicky abdominal pain and tenesmus (Aslam & Okafor, 2022). In children and the elderly, shigellosis can lead to death and other ramifications due to the immune system’s failure to resolve the condition before and after the onset of symptoms.

Mode of Transmission

Shigellosis is a multifactorial condition meaning it has various transmission paths. According to Aslam & Okafor (2022), the primary transmission path for shigellosis is the fecal-oral route during sexual contact with infected persons. in less developing regions, the disease transmits through water-and-food-borne transmission paths. Based on these transmission patterns, it is essential to note that children, the elderly, and people with poor social determinants of health, including poor housing, food insecurity, poverty, and low-level education attainment are at-risk people for shigellosis.


Often, the immune system combats the Shigella infections to prevent the advancement of symptoms. However, in cases where the immune system fails to protect the body from pathogens, the disease advanced to result in multiple complications that compromise individual health. Mayo Clinic (2020) identifies dehydration, hemolytic uremic syndrome, rectal prolapse, bacteremia, reactive arthritis, and toxic megacolon as the long-term complications of untreated shigellosis. Dehydration, rectal prolapse, and hemolytic uremic reaction are among the concerns that render Shigella infections deadly, especially in children.


Various pharmacologic and non-pharmacologic interventions are effective in preventing and treating shigellosis. Firstly, medical approaches focus on alleviating the disease’s systems. Islam & Okafor (2022) identify hydration and electrolyte management as profound medical measures for addressing shigella symptoms, including dehydration. Other pharmacological actions include administering second-generation medications like cephalosporin, ampicillin, and trimethoprim-sulfamethoxazole. For children with Shigella infections, healthcare professionals can administer azithromycin, cefixime, ceftibuten, and other first-line drugs.

On the other hand, non-pharmacologic strategies focus on self-management and improving determinants of health that contribute to individual susceptibility to Shigella infections. Cleveland Clinic (2022) identify hand hygiene, adherence to safe food and water instructions, avoiding sexual contact with infected persons, and disinfecting diaper-changing areas as proven options for preventing Shigellosis. These strategies emphasize the interception of the transmission patterns for disease-causing pathogens. Therefore, they are crucial for reducing the population’s propensity to the disease.

Demographic Breakdown

Although everyone is susceptible to Shigella bacillus, the disease results in disproportionate effects on children, the elderly, and people with poor social determinants of health, including poor housing, food insecurity, and poor sanitation. According to Aslam & Okafor (2022), the disease’s incidence is approximately 188 million annual cases with about a million deaths. In developed countries, the disease’s incidence is around 1.5 million cases annually. Aslam & Okafor (2022) contend that shigella infections are common among young children (≤4 years) with a prevalence rate of 28 cases per 100,000 children. Similarly, children aged 4-11 years are vulnerable to the disease, whose prevalence rate is about 25 cases per 100,000 children in this age group. The knowledge of age as a core determinant of individual propensity to the disease enables healthcare professionals to implement evidence-based and population-centered interventions for preventing and managing the disease.


Determinants of Health

Social determinants of health are “the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks” (Healthy People 2030, n.d.). The five domains of core determinants of health are economic stability, access to quality education, access to quality healthcare, neighborhood and built environment, and social/community contexts. These factors create preventable health inequalities and disparities that expose people to multiple healthcare issues. In the context of Shigella infections, different aspects of these social determinants of health contribute to disproportionate effects and prevalence. For instance, about 9% of children live in poverty in Alameda County, California (County Health Ranking & Roadmaps, 2022). Further, about 8.8% of people struggle with unemployment, while 8% of Alameda residents grapple with food insecurity. These factors can increase their susceptibility to Shigella infections.

Epidemiological Triad

Shigella infections’ prevalence and incidences rely massively upon the interactions between hosts, agents, and environmental aspects like sanitation, overcrowding, and housing. The epidemiological triad enshrines the three components to enable healthcare professionals to understand factors that contribute to the disease’s disproportionate effects, prevalence, and incidences

Host Factors

Humans are the primary natural reservoirs for all four Shigella serotypes. However, the disease’s effects rely massively upon intrinsic factors like immunity and age. According to the Centers for Disease Control and Prevention [CDC] (2021), people with poor underlying health conditions like HIV or undergoing various medical treatment interventions like chemotherapy for cancer are highly susceptible to the disease. In this sense, diseases like HIV and medical treatment options weaken immune systems, affecting the body’s ability to combat Shigella infections.

Agent Factors

Shigella bacteria has four serotypes that are responsible for Shigellosis; Shigella dysenteriae, Shigella flexneri, Shigella boydii, and Shigella soneii. According to Aslam & Okafor (2022), these pathogenic serotypes are resistant to acid in the stomach and multiply in the small intestine before entering the colon. Also, these bacteria produce Shigella enterotoxins and serotype toxin 1, causing bloody diarrhea.

Environmental Factors

Although host and agent factors are responsible for Shigellosis transmission and prevalence, pathogens require appropriate environmental aspects that bridge the chasm between vectors and hosts. Chen et al. (2019) identify climatic factors, such as changes in weather variables like temperature, precipitation, humidity, and wind speed as aspects that impact the three epidemiological components of infections; pathogens, hosts/vectors, and transmission. Poor sanitation, water pollution, overcrowding, and poor housing are equally fundamental in determining Shigellosis transmission, prevalence, and incidences.

Role of the Nurse Practitioner (NP)

Nurse practitioners (NPs) participate in collaborative health interventions and provide multiple healthcare services, including health promotion, disease prevention, health education, counseling, and the diagnosis and management of acute and chronic conditions (American Association of Nursing Practitioners, n.d.). In all-concerted efforts to prevent Shigellosis, nurses can participate in surveillance, data collection, early screening, data analysis, and follow-up. Equally, they spearhead pharmacological and non-pharmacologic preventive and treatment interventions by administering oral hydration treatment, educating people on hygienic measures like hand washing practices, conducting timely screening of Shigella infections, participating in food safety policies, and assessing social determinants of health that increase people’s susceptibility to the disease.

Finally, nursing practitioners are responsible for incorporating evidence-based interventions for improving individual and community health in response to Shigella infections. John Hopkins Nursing Evidence-Based Practice Model (JHNEBP) is among the profound frameworks that enable nurses to enculture evidence-based practice (EBP) and utilize research as a tool for informing practices and decisions. According to Speroni et al. (2020), this model requires nurses to develop foreground questions using a team approach, select and appraise evidence, and translate theoretical knowledge to practice. The PET (Practice question, Evidence, and Translation) steps are effective as problem-solving and decision-making approaches.


Shigellosis is a highly transmissible disease that results in poor health outcomes and other adverse consequences, including deaths, life-threatening conditions like diarrhea, and prolonged hospitalization. Equally, the disease results in a massive economic burden associated with medications and other clinical processes. Healthcare professionals should understand the epidemiological triad that enshrines interactions between hosts, agents, and the environment to implement informed and evidence-based preventive interventions. Nurse practitioners should play a forefront role in preventing and managing Shigellosis by surveying and tracking cases of Shigella infections, collecting, analyzing, and reporting data to policymakers, educating at-risk populations, following up on the progress of infected people, and incorporating evidence-based practices for managing the disease.


American Association of Nurse Practitioners. (n.d.). Scope of practice for nurse practitioners. Retrieved May 9, 2022, from

Aslam, A., & Okafor, C. (2022). Shigella. StatPearls.

Baker, S., & The, H. C. (2018). Recent insights into Shigella. Current Opinion in Infectious Diseases, 31(5), 449–454.

Centers for Disease Control and Prevention. (2021). Shigella – Shigellosis.

Centers for Disease Control and Prevention. (2022). Sources of infection & risk factors.

Chen, C.-C., Lin, C.-Y., & Chen, K.-T. (2019). Epidemiologic features of shigellosis and associated climatic factors in Taiwan. Medicine, 98(34), e16928.

Cleveland Clinic. (2022). Shigella infection (shigellosis): Causes, symptoms & treatment. Cleveland Clinic.

County Health Rankings & Roadmaps. (2022). Alameda, California.

Healthy People 2030. (n.d.). Social determinants of health. Retrieved November 27, 2022, from

Mayo Clinic. (2020). Shigella Infection – Symptoms and Causes.

Speroni, K. G., McLaughlin, M. K., & Friesen, M. A. (2020). Use of evidence‐based practice models and research findings in magnet‐designated hospitals across the United States: National survey results. Worldviews on Evidence-Based Nursing, 17(2), 98–107.



Choose a topic from the list provided to you by your course faculty.

Week 5: Infectious Disease Paper: (Choose one of the following: infectious diseases), i live in Dublin California.


Apply the concepts of population health and epidemiology to the topic.
Synthesize Course content from Weeks 1-5 according to the following sections:
Introduction: Analysis of the communicable disease (causes, symptoms, mode of transmission, complications, treatment) to include demographic break down that includes age, gender, race, or other at-risk indicators (da ta per demographics should include mortality, morbidity, incidence, and prevalence).
Determinants of Health: Define, identify and synthesize the determinants of health as related to the development of the infection. Utilize HP2020.
Epidemiological Triad: Identify and describe all elements of the epidemiological triad: Host factors, agent factors (presence or absence), and environmental factors. Utilize the demographic break down to fur ther describe the triad.
Role of the NP: Succinctly define the role of the nurse practitioner according to a national nurse practitioner organization ( National Board of Nursing or AANP, for example) and synthesize the role to the management of infectious diseases (surveillance, primary/secondary/tertiary interventions, reporting, data collecting, data analysis, and follow-up). This includes the integration of a model of practice which supports the implementation of an evidence-based practice.  Refer to your course textbook for models of practice examples.
Preparing the paper
Submission Requirements

Application: Use Microsoft Wordâ„¢ to create the written assessment.
Length: The paper (excluding the title page and reference page) should be limited to a maximum of four (4) pages. Papers not adhering to the page length may be returned to you for editing to meet the length guidelines .
A minimum of three (3) scholarly research/literature references must be used. CDC or other web sources may be utilized but are not counted towards the three minimum references required. Your course text may be used as an additional resource but is not included in the three minimum scholarly references.
APA format current edition.
Include scholarly in-text references and a reference list.
Adhere to the Chamberlain College of Nursing academic policy on integrity as it pertains to the submission of student created original work for assignments .
Do not write in the first person (such as “me” “I”)
Best Practices in Preparing the Project

The following are best practices in preparing this project:

Review directions and rubric thoroughly.
Follow submission requirements.
Make sure all elements on the grading rubric are included. Organize the paper using the rubric sections and appropriate headings to match the sections.
Rules of grammar, spelling, word usage, and punctuation are followed and consistent with formal, scientific writing.
Title page, running head, body of paper, and reference page must follow APA guidelines as found in the current edition of the manual. This includes the use of headings for each section of the paper except for the introduction where no heading is used.
Ideas and information that come from scholarly literature must be cited and referenced correctly.
A minimum of three (3) scholarly literature references must be used. **See above section on “Preparing the Paper”.
Abide by Chamberlain College of Nursing academic integrity policy.

Struggling to meet your deadline ?

Get assistance on

NR 503: Infectious Disease Paper

done on time by medical experts. Don’t wait – ORDER NOW!

Open chat
WhatsApp chat +1 908-954-5454
We are online
Our papers are plagiarism-free, and our service is private and confidential. Do you need any writing help?